Clinical Trial Update: A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour [Phase 2]

View source ↗

Summary

A Phase II clinical study evaluating HRS-7058 in combination with antitumor drugs for patients with advanced malignant tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• HRS-7058 (HRS-7058)

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Advanced Malignant Tumour | Phase 2 | Status: RECRUITING